Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × OTHER × Digestive Neuroendocrine Tumors × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Breast Neoplasms 547 Colorectal Neoplasms 246 Neoplasms 230 Prostatic Neoplasms 218 Carcinoma, Non-Small-Cell Lung 194 Stomach Neoplasms 153 Leukemia, Myeloid, Acute 149 Carcinoma, Hepatocellular 146 Lung Neoplasms 135 Rectal Neoplasms 134 Multiple Myeloma 132 Nasopharyngeal Carcinoma 109 Colonic Neoplasms 106 Neoplasm Metastasis 100 Precursor Cell Lymphoblastic Leukemia-Lymphoma 86 Lymphoma 85 Uterine Cervical Neoplasms 83 Pancreatic Neoplasms 82 Lymphoma, Large B-Cell, Diffuse 79 Leukemia 78 Ovarian Neoplasms 77 Head and Neck Neoplasms 77 Esophageal Neoplasms 74 Lymphoma, Follicular 72 Brain Neoplasms 70 Squamous Cell Carcinoma of Head and Neck 64 Recurrence 64 Leukemia, Lymphocytic, Chronic, B-Cell 59 Lymphoma, Non-Hodgkin 58 Pain 56

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02465112 2019-02-28

TERAVECT

GERCOR - Multidisciplinary Oncology Cooperative Group

Phase 3 Terminated

Digestive Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡